促销时间表 Vertex
先进的时间表
简单图表
关于公司
Vertex Pharmaceuticals Incorporated занимается разработкой и коммерциализацией методов лечения муковисцидоза. Компания продает SYMDEKO / SYMKEVI, ORKAMBI и KALYDECO для лечения пациентов с муковисцидозом, у которых есть специфические мутации в гене трансмембранного регулятора муковисцидоза; и TRIKAFTA для лечения пациентов с CF в возрасте 12 лет и старше, у которых есть по меньшей мере одна мутация F508del в регуляторе трансмембранной проводимости муковисцидоза или гене CFTR. 更多详情IPO date | 1991-07-24 |
---|---|
ISIN | US92532F1003 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Див.доход ао | |
Дивиденд ао | |
Сайт | http://www.vrtx.com |
Цена ао | 409.56 |
每日价格变化: | -0.025% (439.73) |
---|---|
每周价格变化: | +4.18% (422) |
每月价格变化: | +7.7% (408.18) |
3个月内价格变化: | -7.97% (477.7) |
六个月内的价格变化: | -12.53% (502.6) |
每年价格变化: | +2.2% (430.17) |
3年内价格变化: | +77.98% (247.01) |
5年内价格变化: | +94.74% (225.75) |
10年价格变化: | +421.25% (84.34) |
年初以来价格变化: | +7.55% (408.76) |
|
低估
|
效率
|
|||||||||||||||||||||||||||||||||||||
股息
|
责任
|
成长冲动
|
交易日期 | 披露日期 | 内幕 | 类型 | 价格 | 体积 | 数量 | 分享最多, % | 之后分享, % | 文档 |
---|---|---|---|---|---|---|---|---|---|
23.01.2025 | 23.01.2025 | ITEM SECOND IRR. TRUST FBO KYL 10% Owner |
销售 | 56.52 | 1 026 230 | 18157 | 0 | -0.04 | 关联 |
22.01.2025 | 23.01.2025 | ITEM SECOND IRR. TRUST FBO KYL 10% Owner |
销售 | 56.48 | 3 041 050 | 53843 | 0 | -0.13 | 关联 |
12.12.2024 | 16.12.2024 | Westphal Jeffrey |
销售 | 53.01 | 30 480 800 | 575000 | 0 | -1.41 | 关联 |
06.12.2024 | 06.12.2024 | Stamm John Richard Director |
购买 | 56.11 | 214 060 | 3815 | 0 | 0.01 | 关联 |
09.10.2024 | 09.10.2024 | ITEM SECOND IRR. TRUST FBO ANN 13(D) GROUP MEMBER |
销售 | 41.31 | 2 022 410 | 48957 | 0 | -0.12 | 关联 |
09.10.2024 | 09.10.2024 | ITEM SECOND IRR. TRUST FBO JAC 13(D) GROUP MEMBER |
销售 | 41.31 | 2 028 900 | 49114 | 0 | -0.12 | 关联 |
08.10.2024 | 09.10.2024 | ITEM SECOND IRR. TRUST FBO ANN 13(D) GROUP MEMBER |
销售 | 41.32 | 1 145 890 | 27732 | 0 | -0.07 | 关联 |
08.10.2024 | 09.10.2024 | ITEM SECOND IRR. TRUST FBO JAC 13(D) GROUP MEMBER |
销售 | 41.32 | 1 158 080 | 28027 | 0 | -0.07 | 关联 |
07.10.2024 | 09.10.2024 | ITEM SECOND IRR. TRUST FBO ANN 13(D) GROUP MEMBER |
销售 | 41.02 | 1 974 540 | 48136 | 0 | -0.12 | 关联 |
07.10.2024 | 09.10.2024 | ITEM SECOND IRR. TRUST FBO JAC 13(D) GROUP MEMBER |
销售 | 41.02 | 2 162 290 | 52713 | 0 | -0.13 | 关联 |
04.10.2024 | 04.10.2024 | ITEM SECOND IRR. TRUST FBO ANN Member of immediate family of |
购买 | 40.72 | 20 360 000 | 500000 | 0 | 1.23 | 关联 |
05.04.2024 | 09.04.2024 | Westphal Jeffrey 10% Owner |
销售 | 30.05 | 23 773 500 | 791133 | 0 | -1.94 | 关联 |
20.03.2024 | 20.03.2024 | 2020 IRREVOCABLE TRUST FOR BEN 13(D) GROUP MEMBER |
销售 | 30.04 | 328 217 | 10926 | 0 | -0.03 | 关联 |
20.03.2024 | 20.03.2024 | ITEM SECOND IRR. TRUST FBO ANN 13(D) GROUP MEMBER |
销售 | 30.04 | 327 947 | 10917 | 0 | -0.03 | 关联 |
20.03.2024 | 20.03.2024 | ITEM SECOND IRR. TRUST FBO JAC 13(D) GROUP MEMBER |
销售 | 30.04 | 329 088 | 10955 | 0 | -0.03 | 关联 |
19.03.2024 | 20.03.2024 | 2020 IRREVOCABLE TRUST FOR BEN 13(D) GROUP MEMBER |
销售 | 30.06 | 930 477 | 30954 | 0 | -0.08 | 关联 |
19.03.2024 | 20.03.2024 | ITEM SECOND IRR. TRUST FBO ANN 13(D) GROUP MEMBER |
销售 | 30.05 | 929 777 | 30941 | 0 | -0.08 | 关联 |
19.03.2024 | 20.03.2024 | ITEM SECOND IRR. TRUST FBO JAC 13(D) GROUP MEMBER |
销售 | 30.06 | 937 060 | 31173 | 0 | -0.08 | 关联 |
18.03.2024 | 20.03.2024 | 2020 IRREVOCABLE TRUST FOR BEN 13(D) GROUP MEMBER |
销售 | 30.05 | 208 968 | 6954 | 0 | -0.02 | 关联 |
18.03.2024 | 20.03.2024 | ITEM SECOND IRR. TRUST FBO ANN 13(D) GROUP MEMBER |
销售 | 30.05 | 207 646 | 6910 | 0 | -0.02 | 关联 |
18.03.2024 | 20.03.2024 | ITEM SECOND IRR. TRUST FBO JAC 13(D) GROUP MEMBER |
销售 | 30.04 | 209 289 | 6967 | 0 | -0.02 | 关联 |
14.03.2024 | 14.03.2024 | 2020 IRREVOCABLE TRUST FOR BEN 13(D) GROUP MEMBER |
销售 | 30.01 | 256 826 | 8558 | 0 | -0.02 | 关联 |
13.03.2024 | 14.03.2024 | 2020 IRREVOCABLE TRUST FOR BEN 13(D) GROUP MEMBER |
销售 | 30 | 42 360 | 1412 | 0 | 0 | 关联 |
12.12.2023 | 12.12.2023 | ITEM SECOND IRR. TRUST FBO ANN 13(D) GROUP MEMBER |
销售 | 28.88 | 1 228 990 | 42555 | 0 | -0.1 | 关联 |
11.12.2023 | 12.12.2023 | ITEM SECOND IRR. TRUST FBO ANN 13(D) GROUP MEMBER |
销售 | 28.73 | 2 034 720 | 70822 | 0 | -0.17 | 关联 |
08.12.2023 | 12.12.2023 | ITEM SECOND IRR. TRUST FBO ANN 13(D) GROUP MEMBER |
销售 | 28.64 | 1 057 020 | 36907 | 0 | -0.09 | 关联 |
04.12.2023 | 04.12.2023 | ITEM SECOND IRR. TRUST FBO ANN 13(D) GROUP MEMBER |
销售 | 27.82 | 525 798 | 18900 | 0 | -0.05 | 关联 |
01.12.2023 | 04.12.2023 | ITEM SECOND IRR. TRUST FBO ANN 13(D) GROUP MEMBER |
销售 | 27.76 | 2 084 780 | 75100 | 0 | -0.18 | 关联 |
30.11.2023 | 04.12.2023 | ITEM SECOND IRR. TRUST FBO ANN 13(D) GROUP MEMBER |
销售 | 27.98 | 2 333 530 | 83400 | 0 | -0.2 | 关联 |
14.09.2023 | 18.09.2023 | DeStefano David PRESIDENT & CEO |
购买 | 2.96 | 1 484 300 | 501453 | 0 | 1.23 | 关联 |
26.08.2023 | 23.08.2024 | ITEM SECOND IRR. TRUST FBO KYL 10% Owner |
购买 | 35.81 | 5 690 210 | 158900 | 0 | 0.39 | 关联 |
14.07.2023 | 14.07.2023 | Westphal Jeffery 10% Owner |
销售 | 18.66 | 1 665 140 | 89236 | 0 | -0.22 | 关联 |
13.07.2023 | 14.07.2023 | Westphal Jeffery 10% Owner |
销售 | 18.91 | 2 933 810 | 155146 | 0 | -0.38 | 关联 |
12.07.2023 | 14.07.2023 | Westphal Jeffery 10% Owner |
销售 | 18.9 | 1 527 420 | 80816 | 0 | -0.2 | 关联 |
30.06.2023 | 05.07.2023 | Westphal Jeffery 10% Owner |
销售 | 19.08 | 11 615 900 | 608798 | 0 | -1.49 | 关联 |
28.06.2023 | 30.06.2023 | Westphal Jeffery 10% Owner |
销售 | 18.26 | 14 608 000 | 800000 | 0 | -1.96 | 关联 |
21.04.2023 | 21.04.2023 | Tensile Capital Management LP 10% Owner |
销售 | 22.32 | 97 829 | 4383 | 0 | -0.01 | 关联 |
20.04.2023 | 21.04.2023 | Tensile Capital Management LP 10% Owner |
销售 | 22.35 | 1 225 790 | 54845 | 0 | -0.13 | 关联 |
19.04.2023 | 21.04.2023 | Tensile Capital Management LP 10% Owner |
销售 | 22.61 | 1 001 920 | 44313 | 0 | -0.11 | 关联 |
04.04.2023 | 04.04.2023 | ITEM SECOND IRR. TRUST FBO JAC 13(D) GROUP MEMBER |
销售 | 21.41 | 781 015 | 36479 | 0 | -0.09 | 关联 |
04.04.2023 | 04.04.2023 | ITEM SECOND IRR. TRUST FBO ANN 13(D) GROUP MEMBER |
销售 | 21.41 | 781 037 | 36480 | 0 | -0.09 | 关联 |
03.04.2023 | 04.04.2023 | ITEM SECOND IRR. TRUST FBO JAC 13(D) GROUP MEMBER |
销售 | 21.05 | 570 939 | 27123 | 0 | -0.07 | 关联 |
03.04.2023 | 04.04.2023 | ITEM SECOND IRR. TRUST FBO ANN 13(D) GROUP MEMBER |
销售 | 21.05 | 570 939 | 27123 | 0 | -0.07 | 关联 |
31.03.2023 | 04.04.2023 | ITEM SECOND IRR. TRUST FBO JAC 13(D) GROUP MEMBER |
销售 | 20.77 | 672 263 | 32367 | 0 | -0.08 | 关联 |
31.03.2023 | 04.04.2023 | ITEM SECOND IRR. TRUST FBO ANN 13(D) GROUP MEMBER |
销售 | 20.77 | 672 263 | 32367 | 0 | -0.08 | 关联 |
16.03.2023 | 16.03.2023 | Westphal Jeffery 10% Owner |
销售 | 17.75 | 24 409 200 | 1375164 | 0 | -3.37 | 关联 |
15.03.2023 | 16.03.2023 | Westphal Jeffery 10% Owner |
销售 | 18.51 | 2 042 120 | 110325 | 0 | -0.27 | 关联 |
14.03.2023 | 16.03.2023 | Westphal Jeffery 10% Owner |
销售 | 18.67 | 445 914 | 23884 | 0 | -0.06 | 关联 |
09.03.2023 | 10.03.2023 | Westphal Jeffery 10% Owner |
销售 | 18.85 | 661 333 | 35084 | 0 | -0.09 | 关联 |
08.03.2023 | 10.03.2023 | Westphal Jeffery 10% Owner |
销售 | 18.63 | 1 171 030 | 62857 | 0 | -0.15 | 关联 |
30.09.2022 | 30.09.2022 | DeStefano David President & CEO |
销售 | 13.94 | 402 866 | 28900 | 0 | -0.07 | 关联 |
29.09.2022 | 30.09.2022 | DeStefano David President & CEO |
销售 | 13.5 | 458 055 | 33930 | 0 | -0.08 | 关联 |
28.09.2022 | 30.09.2022 | DeStefano David President & CEO |
销售 | 13.59 | 494 934 | 36419 | 0 | -0.09 | 关联 |
28.01.2022 | 31.01.2022 | DeStefano David PRESIDENT & CEO |
购买 | 0.15 | 1 050 | 7000 | 0 | 0.03 | 关联 |
机构 | 体积 | 分享, % |
---|---|---|
Vanguard Group Inc | 22282180 | 8.62 |
Blackrock Inc. | 21881203 | 8.47 |
Capital World Investors | 21805770 | 8.44 |
FMR, LLC | 12979511 | 5.02 |
State Street Corporation | 12083818 | 4.68 |
AllianceBernstein L.P. | 7039738 | 2.72 |
Price (T.Rowe) Associates Inc | 5887412 | 2.28 |
Geode Capital Management, LLC | 5673419 | 2.2 |
JP Morgan Chase & Company | 5624265 | 2.18 |
Wellington Management Group, LLP | 5228538 | 2.02 |
导师 | 职称 | 支付 | 出生年份 |
---|---|---|---|
Mr. Charles F. Wagner Jr. | Executive VP & CFO | 2.06M | 1968 (57 年) |
Mr. Mike Tirozzi | SVP and Chief Information & Data Officer | N/A | |
Mr. Stuart A. Arbuckle B.Sc. | Executive VP & COO | 2.7M | 1966 (59 年) |
Dr. David M. Altshuler M.D., Ph.D. | Executive VP & Chief Scientific Officer | 2.03M | 1965 (60 年) |
Dr. Jeffrey Marc Leiden M.D., Ph.D. | Executive Chairman | 92.93k | 1956 (69 年) |
Susie Lisa | Senior Vice President of Investor Relations | N/A | |
Mr. Jonathan Biller J.D. | Executive VP & Chief Legal Officer | N/A | 1964 (61 年) |
Ms. Nina Devlin | Senior VP & Chief Communications Officer | N/A | |
Dr. Reshma Kewalramani FASN, M.D. | CEO, President & Director | 1973 (52 年) | |
Ms. Kristen C. Ambrose CPA | Senior VP & Chief Accounting Officer | 1977 (48 年) |
地址: United States, Boston, MA , 50 Northern Avenue - 在 Google 地图中打开, 打开 Yandex 地图
网站: http://www.vrtx.com
网站: http://www.vrtx.com